Bellevue Group’s Structure Therapeutics GPCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.23M | Buy |
348,527
+126,812
| +57% | +$2.63M | 0.16% | 72 |
|
|
2025
Q1 | $3.84M | Sell |
221,715
-263,335
| -54% | -$4.56M | 0.09% | 92 |
|
|
2024
Q4 | $13.2M | Sell |
485,050
-144,708
| -23% | -$3.92M | 0.25% | 73 |
|
|
2024
Q3 | $27.6M | Buy |
629,758
+72,437
| +13% | +$3.18M | 0.45% | 65 |
|
|
2024
Q2 | $21.9M | Buy |
557,321
+193,395
| +53% | +$7.59M | 0.36% | 69 |
|
|
2024
Q1 | $15.6M | Buy |
363,926
+351,626
| +2,859% | +$15.1M | 0.24% | 86 |
|
|
2023
Q4 | $501K | Sell |
12,300
-4,500
| -27% | -$183K | 0.01% | 135 |
|
|
2023
Q3 | $847K | Buy |
+16,800
| New | +$847K | 0.01% | 134 |
|